IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRLAB Therapeutics AB
Accounts Payable Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Accounts Payable
kr10.5m
CAGR 3-Years
42%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Accounts Payable
kr151m
CAGR 3-Years
37%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Accounts Payable
kr70m
CAGR 3-Years
30%
CAGR 5-Years
31%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Accounts Payable
kr116.7m
CAGR 3-Years
65%
CAGR 5-Years
93%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Accounts Payable
kr6.8m
CAGR 3-Years
32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Accounts Payable
kr1.1m
CAGR 3-Years
-51%
CAGR 5-Years
-36%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Accounts Payable?
Accounts Payable
10.5m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Accounts Payable amounts to 10.5m SEK.

What is IRLAB Therapeutics AB's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
12%

Over the last year, the Accounts Payable growth was 5%. The average annual Accounts Payable growth rates for IRLAB Therapeutics AB have been 42% over the past three years , 12% over the past five years .

Back to Top